The Single-Action Pace Semaglutide operates by targeting a single path to curb appetite
How can you maintain weight loss after stopping a GLP-1
Triple Agonist vs Dual Agonist Comparison Contents Key Takeaways Two Compounds, One Manufacturer, Different Receptor Counts Weight Loss: The Numbers Side by Side Mechanism Breakdown: What the Third Receptor Adds Safety: Where the Tradeoffs Appear Evidence Quality: Phase 2 vs Phase 3 Where Each Compound Might Win The Bottom Line Explore Research Peptides Retatrutide 12mg 24.2% body weight lost (Phase 2, 48 wk) vs Tirzepatide 15mg 22.5% body weight lost (Phase 3, 72 wk) 3 vs 2 receptor targets (retatrutide vs tirzepatide) 63% vs 57% reached 20%+ weight loss (highest dose arms) Eli Lilly same manufacturer for both compounds Sources: Retatrutide Phase 2 (NEJM, 2023), SURMOUNT-1 (NEJM, 2022)
Join now Activity 260 followers Judith Stern Judith Stern 1yJudith Stern posted thisSince my last post, Ive started a new position with Intra Cellular Therapies, ITCI Inc
She has helped me and many others feel better about ourselves
semaglutide highlights this stacking logic, which explains the documented progression in efficacy
